Extrapulmonary effects of alternate-day prednisone and inhaled beclomethasone
dipropionate therapy were examined in 24 and 32 children with asthma, respectively. Early …

Inhaled corticosteroid (ICS) therapy carries less risk of complicating drug-or disease-related
morbidity and mortality than that associated with other antiasthmatic drugs such as …

Background: Results of recent growth studies suggest that inhaled glucocorticosteroids may
affect growth in children. Objective: Three 52-week, open-label extension studies (studies A …

In a controlled prospective study we have measured growth and pulmonary function in
children with asthma during long-term treatment with inhaled budesonide and compared …

Inhaled corticosteroids (ICS) are now first‐line therapy for persistent asthma in children. The
major safety concerns of long‐term ICS therapy for childhood asthma are potential effects on …

Inhaled corticosteroids play a pivotal role in the treatment of asthma. Inhalation permits
effective delivery of the corticosteroid in high concentration to target sites within the lung …

Inhaled corticosteroids are considered by many to be the anti-inflammatory therapy of choice
in adult asthma, given their remarkable efficacy and apparent safety. They are presently …

Inhaled steroids are frequently used in childhood asthma, but concerns based on limited
objective evidence remain, regarding long-term side-effects. In this study the systemic effects …

Poorly controlled severe asthma can lead to growth impairment in childhood. In children with
mild asthma, it is less clear whether treatment influences growth or adrenal function. We …

The purpose of this review is to provide the clinician with an update on the potential adverse
effects caused by the inhaled corticosteroids (ICSs). The systemic effects of ICSs are a result …